Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:50 PM
Ignite Modification Date:
2025-12-24 @ 3:50 PM
NCT ID:
NCT03084692
Eligibility Criteria:
Inclusion Criteria:
1. Diagnosis of Primary Lung Cancer Stage I-IV (all stages)
2. Any form of Lung cancer included: Small Cell Lung Cancer and Non-Small Cell Lung Cancer
3. Age: 18 years or above
4. Patients at any time point during treatment: ongoing treatment, completed treatment or recently diagnosed and about to start treatment
5. Karnofsky Performance Status ≥ 50 (Appendix A)
6. Life expectancy at least one year -
Exclusion Criteria:
1. Metastatic lung disease that would preclude safe exercise prescription
2. Secondary Lung cancer due to metastasis from other parts of body
3. Co-morbid conditions such as diabetes, congestive heart failure, dementia, cerebrovascular diseases.
4. Individuals who would be unsafe to participate in an intervention program.
5. Unable to provide consent in English
6. Unable to complete either testing or intervention components (e.g. extended holiday)
Caregiver eligibility: Caregivers will be screened using the PAR-Q + questionnaire and will be required to obtain approval from a family physician should any safety concerns be identified.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03084692
Study Brief:
Protocol Section:
NCT03084692